Emerging Psilocybin Therapy for End-of-Life Distress
Insights into a new study exploring risks, benefits, and applications for advanced cancer patients
Topline
A recent human study highlights both the potential benefits and the notable risks of psilocybin and other hallucinogens in patients facing end-of-life psychological distress, especially among those with advanced cancer and existing comorbidities. While these substances show promise for improving mood and quality of life in carefully controlled cl…



